WASHINGTON, May 19 (Reuters) - Abbott Laboratories (ABT.N) and the U.S. Food and Drug Administration are on track to reopen the company's Sturgis, Michigan, baby formula manufacturing plant within on… [+604 chars]Read the whole story by on Reuters:https://www.reuters.com/business/retail-consumer/abbott-baby-formula-plant-track-reopen-within-1-2-weeks-fda-commissioner-2022-05-19/